Stockscreener 앱 받기
2.92
19.34%
-0.70
시장 영업 전:
2.92
전일 마감가:
$3.62
열려 있는:
$3.29
하루 거래량:
474.94K
Relative Volume:
22.26
시가총액:
$138.24M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-81.75%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$2.80
$5.00
1주일 범위
$2.80
$17.20
52주 변동 폭
$2.80
$33.90
Polaryx Therapeutics Inc Stock (PLYX) Company Profile
Compare PLYX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLYX
Polaryx Therapeutics Inc
|
2.92 | 171.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Polaryx Therapeutics Inc 주식(PLYX)의 최신 뉴스
Polaryx Therapeutics, Inc. Rings the Closing Bell - Nasdaq
Polaryx to evaluate PLX-200 for Krabbe disease in Phase 2 trial - Investing.com Canada
Polaryx announces pre-clinical data related to Soteria - TipRanks
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ - The Manila Times
In mice with Krabbe disease, Polaryx drug restored movement, extended life - Stock Titan
Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings - Benzinga
Morning Market Movers: UOKA, KD, HIMS, PGY See Big Swings - RTTNews
Strategy, Bitmine Immersion Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why STMicroelectronics Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Finance Watch: Four IPOs In One Week - Citeline News & Insights
Polaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board - TipRanks
Polaryx Therapeutics (PLYX) Valuation Check After Sharp Single Day Share Price Decline - simplywall.st
Cerence Inc. (CRNC) - MSN
Eli Lilly and Oracle among market cap stock movers on Thursday - Investing.com
Polaryx Therapeutics, Inc. Announces Board Changes, Effective January 29, 2026 - marketscreener.com
Polaryx Therapeutics Welcomes New Members of the Board of Directors - The Manila Times
Brain tumor director and biotech CEO join Polaryx board as drug enters Phase 2 - Stock Titan
PLYX - Finviz
INTAPP, INC. (INTA) - MSN
Polaryx to present late-breaker data related to Soteria ahead of trial - Yahoo Finance
IBM, Palantir among market cap stock movers on Tuesday By Investing.com - Investing.com Australia
IBM, Palantir among market cap stock movers on Tuesday - Investing.com
FUBOTV INC. (FUBO) Stock, Price, News, Quotes, Forecast and Insights - MSN
GARTNER, INC. (IT) Stock, Price, News, Quotes, Forecast and Insights - MSN
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch - The Manila Times
New Krabbe disease findings support Polaryx’s 4-indication SOTERIA trial - Stock Titan
Why Teradyne Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Polaryx Therapeutics Announces to Present Late-Breaker Data Related to Soteria At the 22Nd Annual Worthldsymposium as Company Prepares for Soteria Trial Launch - marketscreener.com
The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown - MedCity News
Polaryx Therapeutics, Clinical-Stage Developer of Therapies for Lysosomal Storage Disorders, Files for Nasdaq Capital Market IPO - TradingView
Polaryx announces direct listing on Nasdaq - TipRanks
Polaryx Therapeutics Reports Direct Listing on Nasdaq - marketscreener.com
AQUESTIVE THERAPEUTICS, INC. (AQST) - MSN
Mstone Portfolio Company, Polaryx Therapeutics, Announces Direct Listing on Nasdaq - The Progress Index
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol 'PLYX” - The Manila Times
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX” - marketscreener.com
Rare-disease drug developer Polaryx makes Nasdaq debut today - Stock Titan
Swvl Holdings Corp (SWVL) - MSN
PLYX IPO NewsMicro-cap Polaryx Therapeutics to trade on the Nasdaq today via direct listing - renaissancecapital.com
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq - The Manila Times
Biotech targeting rare pediatric diseases heads to Nasdaq Feb. 2 - stocktitan.net
Skycorp Solar Group Ltd (PN) - MSN
FLYEXCLUSIVE INC. (FLYX) - MSN
Sandhoff Disease Pipeline Analysis Highlights Emerging - openPR.com
DATAVAULT AI INC. (DVLT) Stock, Price, News, Quotes, Forecast and Insights - MSN
DATAVAULT AI INC. (DVLT) - MSN
Evolution Metals & Technologies Corp. (EMAT) - MSN
Uni-Fuels Holdings Limited (UFG) - MSN
Oracle, Nvidia among market cap stock movers on Monday By Investing.com - Investing.com Nigeria
ASCENT SOLAR TECHNOLOGIES, INC. (ASTI) - MSN
Multi Ways Holdings Limited (MWG) - MSN
Polaryx Therapeutics Inc (PLYX) 재무 분석
Polaryx Therapeutics Inc (PLYX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):